Recently, we showed that reduced skeletal muscle insulin sensitivity in RA patients is more likely due to traditional metabolic risk factors such as adiposity than to systemic inflammation or disease-related factors [2]. The gene discussed is INS; the disease is rheumatoid arthritis.